Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,030 evidence items · page 3 / 42

Moderately (type A(+)) and severely (type A(-)) G6PD deficiency showed significant association with lower haemoglobin concentrations at baseline in African children with severe malaria.

Gabonpaludismepublished 2016Malaria journaleurope_pmcdocument of 7 observations

7 %In Dienga, southeastern Gabon, the prevalence of microscopic P. falciparum infection was 7% in 2003.

Gabonpaludismeobserved 2003published 2016PloS oneeurope_pmcdocument of 9 observations

80.8 %At day 28, the PCR-unadjusted efficacy of amodiaquine-artesunate was 80.8%.

Gabonpaludismepublished 2011PLoS medicineeurope_pmcdocument of 15 observations

6.1 %Malaria and COVID-19 co-infections were diagnosed in 3 (6.1%) patients among febrile patients screened in Gabon from October 2021 to December 2021.

GabonCOVID-19 · paludismeobserved October 2021 to December 2021published 2022Southern African journal of infectious diseaseseurope_pmcdocument of 4 observations

69.6 %Malaria infection prevalence was 69.6% among school-aged children in Gabon.

Gabonpaludismeobserved 2021published 2024Tropical medicine and infectious diseaseeurope_pmcdocument of 8 observationsDOI 10.3390/tropicalmed10010011

45.9 %For low-level parasitemias, venous blood microscopy sensitivity dropped to 45.9%.

Gabonpaludismeobserved 2015–2016published 2018The Journal of infectious diseaseseurope_pmcdocument of 8 observationsDOI 10.1093/infdis/jiy319

10.3 %The wild-type D1246 Pfmdr1 genotype prevalence was 10.3% in symptomatic infections and 100% in asymptomatic infections.

Gabonpaludismepublished 2021Infection and drug resistanceeurope_pmcdocument of 10 observationsDOI 10.2147/idr.s304361

4 %In an efficacy open-label clinical trial with a 28-day follow-up in 29 children under five with uncomplicated malaria, PCR-corrected, 1/26 (4%) had an early treatment failure, resulting in early trial discontinuation.

Gabonpaludismepublished 2011Malaria journaleurope_pmcdocument of 5 observationsDOI 10.1186/1475-2875-10-123

6.5 %Vaccine efficacy of GMZ2/alum was 6.5% against clinical malaria over 24 months in the intention-to-treat analysis.

Gabonpaludismepublished 2021VaccinePubMeddocument of 3 observations

0.45 adjusted_odds_ratioParity was associated with Plasmodium falciparum infection, with an adjusted odds ratio of 0.45 for multipara versus paucipara.

Gabonpaludismeobserved 2008–2011published 2013Malaria JournalOpenAlexdocument of 6 observationsDOI 10.1186/1475-2875-12-412

45.4 %The K1/msp-1 allelic family was predominant in urban areas (45.4%) in the Republic of Congo during a cross-sectional survey conducted from March to September 2021.

Gabonpaludismeobserved March to September 2021published 2023Pathogens (Basel, Switzerland)europe_pmcdocument of 8 observationsDOI 10.3390/pathogens12050742

85.3 %PCR-corrected adequate clinical and parasitological response (ACPR) in the per-protocol set was 85.3% for artesunate-pyronaridine-atovaquone-proguanil (APAP) at day 42.

Gabonpaludismepublished 2026The Lancet. Microbeeurope_pmcdocument of 21 observations

397 isolatesA total of 397 (72.4%) Plasmodium falciparum isolates were collected in rural areas in the Republic of Congo during a cross-sectional survey conducted from March to September 2021.

Gabonpaludismeobserved March to September 2021published 2023Pathogens (Basel, Switzerland)europe_pmcdocument of 8 observationsDOI 10.3390/pathogens12050742

87.1 %Day 28 PCR-adjusted adequate clinical and parasitological response (ACPR) was 87.1% (27/31) with 400 mg ferroquine plus 1000 mg artefenomel.

Gabonpaludismepublished 2023Malaria journaleurope_pmcdocument of 13 observations

0.35 rhoThere were strong correlations between cortisol concentration and parasite load in Plasmodium falciparum-infected primigravidae women (rho between 0.35 and 0.45 with P < 0.01).

Gabonpaludismepublished 2005Microbes and infectioneurope_pmcdocument of 7 observations

92 %For low-level parasitemias, capillary and venous blood microscopy specificities were 92%.

Gabonpaludismeobserved 2015–2016published 2018The Journal of infectious diseaseseurope_pmcdocument of 8 observationsDOI 10.1093/infdis/jiy319

4 casesIn four neonatal malaria cases, the Plasmodium species was not reported.

Gabonpaludismepublished 2025BMC infectious diseasesPubMeddocument of 17 observations

79 %In 1995/96, 79% of the isolates carried the same microsatellite alleles in a chromosomal fragment spanning 39 kb surrounding the pfcrt locus.

Gabonpaludismeobserved 1995/96published 2011Malaria journaleurope_pmcdocument of 4 observationsDOI 10.1186/1475-2875-10-304

53.4 %La prévalence de Plasmodium spp. chez les enfants de 5 à 9 ans était de 53,4 %.

GabonpaludismeHAL · Unilimdocument of 81 observations

1,373 parasites/μLLa densité médiane de parasites Plasmodium falciparum était de 1373 parasites/μL chez les enfants porteurs de l’allèle APOE Ɛ4, contre 631 parasites/μL chez les enfants non-porteurs.

GabonpaludismeHAL · Unilimdocument of 81 observations

54.5 %The FC27/msp-2 allelic family was predominant in urban areas (54.5%) in the Republic of Congo during a cross-sectional survey conducted from March to September 2021.

Gabonpaludismeobserved March to September 2021published 2023Pathogens (Basel, Switzerland)europe_pmcdocument of 8 observationsDOI 10.3390/pathogens12050742

0.48 relative_riskThe relative risk of overall malaria infection in the intervention group compared to the control group was 0.48.

Gabonpaludismepublished 2024The Lancet. Infectious diseasesPubMeddocument of 6 observations

38 %FCR-3 strains (F-segment) were found in 19 out of 50 symptomatic children, representing 38%.

Gabonpaludismepublished 2006Clinical medicine & researcheurope_pmcdocument of 7 observationsDOI 10.3121/cmr.4.1.7

33 patientsOf 168 patients, 33 (20%) developed critical disease.

Gabonpaludismeobserved 2013-2023published 2025Journal of travel medicinePubMeddocument of 5 observations

70.6 %Anemia was the most common feature of severe malaria, present in 70.6% of cases (n = 12/17).

Gabonpaludismepublished 2016Parasite (Paris, France)europe_pmcdocument of 9 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.